Novel composition for the treatment of neurological disorders
OwnerMorris Manninventor
Life of this patent
Estimating the term…
Abstract
A non-stoichiometric clathrate of lipid and sulfur has been shown to effectively stabilize nerve cell membranes. As such, said compound has proven useful in a variety of neuropsychiatric disorders such as, addiction, depression, autism, Tourette's syndrome, and the like.
Claims18
1 A composition comprising a clathrate of sulfur containing aliphatic materials.
2 The composition of claim 1 wherein the sulfur is beta sulfur.
3 The composition of claim 1 wherein the aliphatic materials are lipids.
4 The composition of claim 1 wherein the sulfur is beta sulfur and the aliphatic materials are lipids.
5 A composition for the treatment of neurological disorders comprising crystalline sulfur encapsulating aliphatic materials.
6 The composition of claim 5 wherein the crystalline sulfur has a monoclinic space group.
7 The composition of claim 5 wherein the aliphatic materials are lipids.
8 The composition of claim 5 wherein the crystalline sulfur has a monoclinic space group and the aliphatic materials are lipids.
9 A method for the treatment of neurological disorders comprising the step of administering to an animal subject an effective amount of a composition comprising a monoclinic clathrate of sulfur.
10 The method according to claim 9 further including the step of providing the clathrate of sulfur prior to the step of administering the clathrate to the animal subject.
11 The method according to claim 9 wherein the clathrate of sulfur encapsulates aliphatic materials.
12 The method according to claim 11 wherein the aliphatic materials are lipids.
13 The method according to claim 11 wherein the sulfur is beta sulfur.
14 The method according to claim 11 wherein the sulfur is beta sulfur and the aliphatic materials are lipids.
15 A method for stabilizing non-orthorhombie forms of sulfur comprising the steps of converting the orthorhombic forms of sulfur to non-orthorhombic forms of sulfur in the presence of aliphatic materials, thereby creating clathrates of the non-orthorhombic forms of sulfur encapsulating the aliphatic materials.
16 The method according to claim 15 wherein the non-orthorhombic forms of sulfur are monoclinic forms of sulfur.
17 The method according to claim 15 wherein the aliphatic materials are lipids.
18 The method according to claim 15 wherein the non-orthorhombic forms of sulfur are monoclinic forms of sulfur and the aliphatic materials are lipids.